Coherus Oncology Inc

CHRSNASDAQ NMS - GLOBAL MARKET

Health CareBiotechnology

$1.59

-0.060000 (-3.64%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $0.7100Current: $1.5952-Week High: $2.62

Key Statistics

Open

$1.65

Day High

$1.68

Day Low

$1.58

Prev. Close

$1.65

Volume

1.52M

Avg. Volume

—

Market Cap

$245.26M

P/E (TTM)

-1.12

Forward P/E

—

P/B Ratio

—

52W High

$2.62

52W Low

$0.7100

50D MA

$1.71

200D MA

$1.58

Dividend Yield

—

Beta

—

Performance

+1.3%

-8.6%

+24.2%

YTD

+16.1%

+107.6%

About

Nasopharyngeal carcinoma (NPC), or nasopharynx cancer, is the most common cancer originating in the nasopharynx, most commonly in the postero-lateral nasopharynx or pharyngeal recess, accounting for 50% of cases. NPC occurs in children and adults. NPC differs significantly from other cancers of the head and neck in its occurrence, causes, clinical behavior, and treatment. It is vastly more common in certain regions of East Asia and Africa than elsewhere, with viral, dietary and genetic factors implicated in its causation. It is most common in males. It is a squamous cell carcinoma of an undifferentiated type. Squamous epithelial cells are a flat type of cell found in the skin and the membranes that line some body cavities. Undifferentiated cells are cells that do not have their mature features or functions.

www.coherus.com/